A comparative study of atenolol and metoprolol in the treatment of hypertension
- PMID: 7340890
- PMCID: PMC1401943
- DOI: 10.1111/j.1365-2125.1981.tb01326.x
A comparative study of atenolol and metoprolol in the treatment of hypertension
Abstract
1 In an open, randomized cross-over investigation of thirteen patients (nine and four women, aged 37-67 years) with mild or moderate essential hypertension a comparison between atenolol and metoprolol was carried out in order to study the effects of 50, 100 and 200 mg given once daily on blood pressure and heart rate at rest and during exercise. 2 Before one beta-adrenoceptor blocking drug was replaced by the other in a patient an intervening drug-free interval of sufficient length was secured to allow an increase in the blood pressure to pretreatment levels. 3 A maximal fall in blood pressure was achieve with 50 mg atenolol once daily, with no further reduction when the dose was increased to 100 mg or 200 mg. Maximal blood pressure reduction was achieved with 100 mg metoprolol daily, while the hypertensive effect of 50 mg once daily was not consistent. Significant reductions in heart rate in all test situations were observed with 50 mg atenolol, while 200 mg metoprolol 100 was necessary to reduce exercise-induced tachycardia. 4 Atenolol 50 mg and metoprolol 100 mg once daily are efficient in treating mild or moderate hypertension and doses beyond these may not reduce the blood pressure further. On the contrary lower doses than generally recommended may be effective in the individual patient.
Similar articles
-
Atenolol and metoprolol once daily in hypertension.Br Med J (Clin Res Ed). 1982 May 22;284(6328):1514-6. doi: 10.1136/bmj.284.6328.1514. Br Med J (Clin Res Ed). 1982. PMID: 6805588 Free PMC article. Clinical Trial.
-
Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.Br Med J (Clin Res Ed). 1982 Nov 13;285(6352):1387-92. doi: 10.1136/bmj.285.6352.1387. Br Med J (Clin Res Ed). 1982. PMID: 6814568 Free PMC article. Clinical Trial.
-
Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.Acta Med Scand. 1981;209(4):261-6. Acta Med Scand. 1981. PMID: 7015797 Clinical Trial.
-
Treatment with beta-blockers--the value of an even plasma concentration over 24 h.J Clin Pharm Ther. 1997 Jun;22(3):171-9. doi: 10.1046/j.1365-2710.1997.8775087.x. J Clin Pharm Ther. 1997. PMID: 9447471 Review.
-
Tolerability and well-being with metoprolol in a controlled release (CR/ZOK) formulation: a review article.J Clin Pharmacol. 1990 Feb;30(S2):S92-7. doi: 10.1002/j.1552-4604.1990.tb03504.x. J Clin Pharmacol. 1990. PMID: 2179287 Review.
Cited by
-
Antihypertensive activity of once daily metoprolol alone and with chlorthalidone and comparison with a twice daily regimen.Eur J Clin Pharmacol. 1982;23(3):209-13. doi: 10.1007/BF00547555. Eur J Clin Pharmacol. 1982. PMID: 6756932 Clinical Trial.
-
Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial.Sleep. 2012 Oct 1;35(10):1395-402. doi: 10.5665/sleep.2122. Sleep. 2012. PMID: 23024438 Free PMC article. Clinical Trial.
-
Atenolol and metoprolol once daily in hypertension.Br Med J (Clin Res Ed). 1982 May 22;284(6328):1514-6. doi: 10.1136/bmj.284.6328.1514. Br Med J (Clin Res Ed). 1982. PMID: 6805588 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical